Key facts
- It has raised $4.7M; the latest was Accelerator/Incubator in Jan 2025.
- Notable investors include AgeTech Collaborative from AARP, Prophetic Capital Partners, SpringTide Ventures (US).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Tenovi
- ·The full record, as it builds
Funding rounds
No funding rounds for Tenovi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tenovi
Developer of a cellular remote health device designed to monitor patients and securely get patient measurements. The company's device specializes in offering a comprehensive application programming interface integration alternative for data transfer, observation, activation and fulfillment and assists in creating new patient and clinic accounts, reviewing patient data and assigning devices to patients at home, enabling clinicians to provide more accessible healthcare, improve patient outcomes and generate more revenue without compromising time.
- Sector
- Healthcare
- HQ
- Portsmouth, NH, United States
- Founded
- 2020
- Employees
- 34
- Website
- tenovi.com/
- Ownership
- Privately Held (backing)
Tenovi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tenovi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tenovi in its N-PORT filings yet. We sweep new filings monthly.